ClearPoint Neuro has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500. Comparatively, Titan Medical has a beta of 2.14, indicating that its stock price is 114% more volatile than the S&P 500.

Source: https://www.etfdailynews.com/2023/12/11/analyzing-clearpoint-neuro-nasdaqclpt-titan-medical-nasdaqtmdif/

Envestnet Asset Management Inc. bought a new position in shares of ClearPoint Neuro during the 1st quarter valued at approximately $106,000.

Source: https://www.etfdailynews.com/2023/10/27/clearpoint-neuro-nasdaqclpt-research-coverage-started-at-stifel-nicolaus/

Receive News & Ratings for ClearPoint Neuro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ClearPoint Neuro and related companies with MarketBeat.

Source: https://www.etfdailynews.com/2023/10/27/clearpoint-neuro-nasdaqclpt-research-coverage-started-at-stifel-nicolaus/

Receive News & Ratings for ClearPoint Neuro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ClearPoint Neuro and related companies with MarketBeat.

Source: https://www.etfdailynews.com/2023/10/27/clearpoint-neuro-nasdaqclpt-research-coverage-started-at-stifel-nicolaus/